Los puntos clave no están disponibles para este artículo en este momento.
These findings demonstrate that ras mutations are a marker for aggressive cancer behavior and indicate a possible role of ras genotyping to identify thyroid carcinoma subsets associated with poor prognosis.
García‐Rostán et al. (Thu,) studied this question.